Cell Biotech Market Cap

Cell Biotech has a market cap or net worth of 117.78 billion as of May 15, 2026. Its market cap has increased by 32.79% in one year.

Market Cap

117.78B

Enterprise Value

25.15B

Revenue

53.13B

Ranking

n/a

PE Ratio

11.64

Stock Price

17,210.00

Market Cap Chart

Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 117.78B, an increase of 743.24%. That is a compound annual growth rate of 9.62%.

Market Cap History

Date	Market Cap	% Change
May 14, 2026	117.78B	31.27%
Dec 30, 2025	89.72B	-8.13%
Dec 30, 2024	97.66B	27.18%
Dec 28, 2023	76.79B	-11.65%
Dec 29, 2022	86.92B	-34.80%
Dec 30, 2021	133.30B	-19.84%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CORESTEMCHEMON	166.13B
Prestige Biologics	163.28B
QuadMedicine	131.13B
BIO-FD&C	113.48B
NovMetaPharma	112.36B
CHA Vaccine Research Institute	99.67B
TegoScience	96.08B
Choong Ang Vaccine Laboratory	95.82B

Market Cap Rankings